Stanford
-
Cell Therapy Startup With Stanford Roots Unveils $75M to Seek Inflammation Cures
Startup TrX1 develops cell therapies that function like a particular type of regulatory T cell, or Treg, whose role includes dampening inflammation and inducing long-term tolerance. Based on research from Stanford, TrX1’s lead program is a potential therapy for preventing graft-versus-host disease.
-
Atropos Health Launches Evidence Network to Back Its Physician Consult Service
Atropos Health — a company that delivers clinical data to physicians at the point of care to help them treat complex patients — recently launched a clinical advisory board and new evidence network. Both announcements are meant to enhance the credibility and transparency of its physician consult platform, CEO Brigham Hyde said at ViVE in Nashville.
-
Do you advise self-insured employers? You Can Help Us!
Take part in this survey and share some of the trends you are seeing among your clients across healthcare, including chronic conditions, behavioral health and navigation.
-
With New Kind of CAR, Cancer Startup Cargo Refuels With $200M for Cell Therapy Race
Cargo Therapeutics is developing CAR T-cell therapies that overcome ways cancers evade currently available treatments. True to its name, the startup’s approach involves putting more cargo and more complex cargo onto engineered T cells.
-
Devices & Diagnostics, Health Tech
Apple Watch could be used to detect arrhythmias other than AFib, study shows
A study published in Circulation showed that the Apple Watch’s ECG detected some arrhythmias other than atrial fibrillation. The device is currently cleared to take ECGs and general irregular pulse alerts, which could indicate potential cases of atrial fibrillation.
-
Hospitals, Artificial Intelligence, Health Tech
In scramble to respond to Covid-19, hospitals turned to models with high risk of bias
Of 26 health systems surveyed by MedCity News, nearly half used automated tools to respond to the Covid-19 pandemic, but none of them were regulated. Even as some hospitals continued using these algorithms, experts cautioned against their use in high-stakes decisions.
-
FDA-cleared AI devices lack critical information on performance, equity
In a review of 130 FDA-cleared AI tools, researchers found that the vast majority of them relied on retrospective studies. Most of the developers also didn’t share information on how many sites the algorithms had been tested in, or how they performed in different patient demographics.
-
Should Apple’s medical clinics make hospitals quiver in their boots?
Experts differ on whether Apple’s clinics are a threat to hospitals but agree that collaboration with employer clinics is key as is a commitment to outcomes and cost transparency.
-
Stanford study on stress and depression utilizes VivaLNK’s wearable devices
Study participants are using VivaLNK’s Vital Scout wearable patches as researchers examine whether there are associations between stress and depression in teenagers.
-
Trayt Health Seeks to Increase Access to Diagnoses and Treatments
CEO Malekeh Amini explains how Trayt Health can bridge the gap for patients seeking neurological care.
-
Bayer expanding its digital health accelerator program to San Francisco
The German life sciences company plans to bring its accelerator program for digital health startups to San Francisco. It’s now available in Berlin, Moscow, and Shanghai among other places.
-
Scientists have created certain strains of yeast that can produce opioids
Certain opioids could be created using yeast instead of poppies. This raises concerns with the DEA and FBI, but so far it looks like it will be a while before this is even a real option in the lab for mass production.